Resultats de la cerca - Jason Cheng
- Mostrar 1 - 16 resultats de 16
-
1
-
2
-
3
-
4
-
5
Phosphatidylinositide 3-kinase γ regulates key pathologic responses to cholecystokinin in pancreatic acinar cells per Ilya Gukovsky, Jason Cheng, Kyung Jin Nam, Oliver T. Lee, Aurelia Lugea, Lars Fischer, Josef Penninger, Stephen J. Pandol, Anna S. Gukovskaya
Publicat 2004Artigo -
6
-
7
A multiplexed bioluminescent reporter for sensitive and non-invasive tracking of DNA double strand break repair dynamics in vitro and in vivo per Chien, Jasper Che-Yung, Tabet, Elie, Pinkham, Kelsey, da Hora, Cintia Carla, Chang, Jason Cheng-Yu, Lin, Steven, Badr, Christian E, Lai, Charles Pin-Kuang
Publicat 2020Text -
8
<i>Kras</i> mutant genetically engineered mouse models of human cancers are genomically heterogeneous per Wei‐Jen Chung, Anneleen Daemen, Jason Cheng, Jason E. Long, Jonathan E. Cooper, Bu-Er Wang, Christopher Tran, Mallika Singh, Florian Gnad, Zora Modrušan, Oded Foreman, Melissa R. Junttila
Publicat 2017Artigo -
9
Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF–induced neutrophil recruitment per Vernon T. Phan, Xiumin Wu, Jason Cheng, Rebecca X. Sheng, Alicia S. Chung, Guanglei Zhuang, Christopher Tran, Qinghua Song, Marcin Kowanetz, Amy Sambrone, Martha Tan, Y. Gloria Meng, Erica L. Jackson, Franklin Peale, Melissa R. Junttila, Napoleone Ferrara
Publicat 2013Artigo -
10
In vivo gene editing in dystrophic mouse muscle and muscle stem cells per Mohammadsharif Tabebordbar, Kexian Zhu, Jason Cheng, Wei Leong Chew, Jeffrey J. Widrick, Winston X. Yan, Claire Maesner, Elizabeth Y. Wu, Ru Xiao, F. Ann Ran, Le Cong, Feng Zhang, Luk H. Vandenberghe, George M. Church, Amy J. Wagers
Publicat 2016Artigo -
11
In Situ Modification of Tissue Stem and Progenitor Cell Genomes per Jill M. Goldstein, Mohammadsharif Tabebordbar, Kexian Zhu, Leo D. Wang, Kathleen Messemer, Bryan Peacker, Sara Ashrafi Kakhki, Meryem Gonzalez-Celeiro, Yulia Shwartz, Jason Cheng, Ru Xiao, Trisha Barungi, Charles F. Albright, Ya‐Chieh Hsu, Luk H. Vandenberghe, Amy J. Wagers
Publicat 2019Artigo -
12
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer per Bruna Pellini, Russell W. Madison, Merrida Childress, Shoshana T. Miller, Ole Gjoerup, Jason Cheng, Richard S.P. Huang, Michael Krainock, Pratyush Gupta, Wei Zou, David S. Shames, Solomon Moshkevich, M. Ballinger, Minetta C. Liu, Amanda Young, Minu K. Srivastava, Geoffrey R. Oxnard, Mark A. Socinski
Publicat 2023Artigo -
13
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer per Namrata S. Patil, Barzin Y. Nabet, Sören Müller, Hartmut Koeppen, Wei Zou, Jennifer M. Giltnane, Amelia Au‐Yeung, Shyam Srivats, Jason Cheng, Chikara Takahashi, Patrícia E. de Almeida, Avantika S. Chitre, Jane L. Grogan, Linda Rangell, Sangeeta Jayakar, Maureen Peterson, Allison W. Hsia, William O’Gorman, Marcus Ballinger, Romain Banchereau, David S. Shames
Publicat 2022Artigo -
14
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors per Mark Merchant, John G. Moffat, Gabriele Schaefer, Jocelyn Chan, Xi Wang, Christine Orr, Jason Cheng, Thomas Hunsaker, Lily Shao, Stephanie J. Wang, Marie-Claire Wagle, Eva Lin, Peter M. Haverty, Sheerin Shahidi-Latham, Hai Ngu, Margaret Solon, Jeffrey Eastham‐Anderson, Hartmut Koeppen, Shih-Min A. Huang, Jacob B. Schwarz, Marcia Belvin, Daniel C. Kirouac, Melissa R. Junttila
Publicat 2017Artigo -
15
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases per Snahel Patel, Joshua D. Webster, Eugene Varfolomeev, Youngsu Kwon, Jason Cheng, Juan Zhang, Debra L. Dugger, Kate E. Wickliffe, Allie Maltzman, Swathi Sujatha-Bhaskar, Pawan Bir Kohli, Sreema Ramaswamy, Gauri Deshmukh, Bianca M. Liederer, Rina Fong, Greg Hamilton, Patrick J. Lupardus, Patrick Caplazi, Wyne P. Lee, Menno van Lookeren Campagne, Adam R. Johnson, Brent S. McKenzie, Melissa R. Junttila, Kim Newton, Domagoj Vucic
Publicat 2019Artigo -
16
Identification and Analysis of <i>In Vivo</i> VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies per Matthew J. Brauer, Guanglei Zhuang, Maike Schmidt, Jenny Yao, Xiumin Wu, Joshua S. Kaminker, Stefanie S. Jurinka, Ganesh Kolumam, Alicia S. Chung, Adrian M. Jubb, Zora Modrušan, Tomoko Ozawa, C. David James, Heidi Phillips, Benjamin Haley, Rachel N. Tam, Anne C. Clermont, Jason Cheng, Sherry X. Yang, Sandra M. Swain, Daniel S. Chen, Stefan Scherer, Hartmut Koeppen, Ru-Fang Yeh, Peng Yue, Jean-Philippe Stephan, Priti S. Hegde, Napoleone Ferrara, Mallika Singh, Carlos Bais
Publicat 2013Artigo
Eines de cerca:
Matèries relacionades
Biology
Gene
Medicine
Cancer research
Internal medicine
Biochemistry
Cell biology
Genetics
Cancer
Chemotherapy
Computational biology
Immunology
CRISPR
Chemistry
Genome editing
Immune system
Kinase
Oncology
Pathology
Signal transduction
Cas9
Disease
Endocrinology
Gene expression
Genetic enhancement
Genome
Inflammation
KRAS
Lung cancer
MAPK/ERK pathway